Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy.

× No keyword cloud information.

8 in total

1. Repositioning HIV protease inhibitors as cancer therapeutics.

Authors: Wendy B Bernstein; Phillip A Dennis
Journal: Curr Opin HIV AIDS Date: 2008-11 Impact factor: 4.283

2. Nelfinavir induces radiation sensitization in pituitary adenoma cells.

Authors: Jing Zeng; Alfred P See; Khaled Aziz; Saravanan Thiyagarajan; Tarek Salih; Rajendra P Gajula; Michael Armour; Jillian Phallen; Stephanie Terezakis; Lawrence Kleinberg; Kristen Redmond; Russell K Hales; Roberto Salvatori; Alfredo Quinones-Hinojosa; Phuoc T Tran; Michael Lim
Journal: Cancer Biol Ther Date: 2011-10-01 Impact factor: 4.742

3. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.

Authors: John Wilkinson; Alethea Cope; Jas Gill; Dimitra Bourboulia; Peter Hayes; Nesrina Imami; Toru Kubo; Anne Marcelin; Vincent Calvez; Robin Weiss; Brian Gazzard; Chris Boshoff; Frances Gotch
Journal: J Virol Date: 2002-03 Impact factor: 5.103

4. Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.

Authors: Randall J Kimple; Angelina V Vaseva; Adrienne D Cox; Kathryn M Baerman; Benjamin F Calvo; Joel E Tepper; Janiel M Shields; Carolyn I Sartor
Journal: Clin Cancer Res Date: 2010-01-26 Impact factor: 12.531

5. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.

Authors: Mary Cianfrocca; Sandra Lee; Jamie Von Roenn; Anil Tulpule; Bruce J Dezube; David M Aboulafia; Richard F Ambinder; Jeannette Y Lee; Susan E Krown; Joseph A Sparano
Journal: Cancer Date: 2010-08-15 Impact factor: 6.860

Review 6. Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity.

Authors: Tomas Koltai
Journal: F1000Res Date: 2015-01-12

7. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.

Authors: Aude De Gassart; Olivier Demaria; Rébecca Panes; Léa Zaffalon; Alexey G Ryazanov; Michel Gilliet; Fabio Martinon
Journal: EMBO Rep Date: 2016-08-29 Impact factor: 8.807

Review 8. The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.

Authors: Giovanni Barillari; Paolo Monini; Cecilia Sgadari; Barbara Ensoli
Journal: Int J Mol Sci Date: 2018-05-09 Impact factor: 5.923

8 in total